CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 65 enrolled
Drug / intervention
Glarginedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01480843
NCT01480843Phase 4Completed
CompareCT.gov

Simplification of Diabetes Regimen in Elderly Patients Using Glargine

Joslin Diabetes Center·interventional·Posted Nov 29, 2011·Updated Nov 8, 2017

In Brief

A Phase 4 clinical trial evaluating Glargine for Diabetes. Completed, enrolled 65 participants across 1 site.

Detailed Summary

The purpose of this study is to find out if simplifying your diabetes treatment by decreasing number of insulin injections, with the help of a long acting insulin called glargine, can decrease the episodes of low blood glucose.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
CollaboratorsSanofi

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 29, 2011
Enrollment StartJun 1, 2011
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 14.6 years ago

Interventions

Glarginedrug

Use of glargine with/without other glucose lowering agent to simplify insulin regimen in older adults